Dexlansoprazole
Dexilant, Dexilant Solutab (dexlansoprazole) is a small molecule pharmaceutical. Dexlansoprazole was first approved as Dexilant on 2009-01-30. It is used to treat gastroesophageal reflux, heartburn, and peptic esophagitis in the USA. Dexilant's patents are valid until 2032-03-05 (FDA).
Trade Name | Dexilant, Dexilant Solutab |
---|---|
Common Name | Dexlansoprazole |
Indication | gastroesophageal reflux, heartburn, peptic esophagitis |
Drug Class | Antiulcer agents (benzimidazole derivatives) |